Skip to main navigation Skip to search Skip to main content

Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus Adults

  • Sarah E. Messiah
  • , Deepali K. Ernest
  • , Folefac D. Atem
  • , Faisal G. Qureshi
  • , M. Sunil Mathew
  • , Jackson M. Francis
  • , Alicia Wheelington
  • , Marlyn A. Allicock
  • , Bethany R. Cartwright
  • , Benjamin E. Schneider
  • , Nestor de la Cruz-Muñoz
  • , Steven E. Lipshultz
  • , Ildiko Lingvay
  • , Jaime P. Almandoz
  • , Sarah E. Barlow
  • University of Texas Southwestern Medical Center
  • Children's Health System of Texas
  • University of Texas Health Science Center at Houston
  • University of Miami

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

This cross-sectional study analyzed adolescent metabolic and bariatric surgery (MBS) utilization before and after glucagon-like peptide-1 receptor agonist (GLP-1RA) medication approval, comparing trends across race and ethnic groups. Although both MBS and GLP-1RA are effective weight management strategies, adolescent MBS utilization increased, while adult rates declined from 2021 through 2023.

Original languageEnglish
Article number114564
JournalJournal of Pediatrics
Volume282
DOIs
StatePublished - Jul 2025

Keywords

  • adolescents
  • adults
  • bariatric surgery
  • prevalence

Fingerprint

Dive into the research topics of 'Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus Adults'. Together they form a unique fingerprint.

Cite this